{"id":"NCT00759811","sponsor":"Instituto de Cardiologia do Rio Grande do Sul","briefTitle":"METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)","officialTitle":"METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure: Randomized Double-blind, Placebo-controlled Trial (METIS Trial)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-12","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2008-09-25","resultsPosted":"2013-05-08","lastUpdate":"2013-05-08"},"enrollment":50,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure","Myocardial Ischemia"],"interventions":[{"type":"DRUG","name":"Methotrexate","otherNames":["Rheumatrex","Trexall"]},{"type":"DRUG","name":"Placebo","otherNames":["Control"]}],"arms":[{"label":"Methotrexate","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The aim of the study is to evaluate the efficacy of methotrexate to improve physical capacity in patients with symptomatic ischemic heart failure.","primaryOutcome":{"measure":"Change in Physical Capacity Measured Using the 6-minute Walk Test Distance","timeFrame":"Baseline and 12 weeks","effectByArm":[{"arm":"Methotrexate","deltaMin":24.5,"sd":39.5},{"arm":"Placebo","deltaMin":21.3,"sd":43.7}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":16},"locations":{"siteCount":1,"countries":["Brazil"]},"refs":{"pmids":["19944358"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":23},"commonTop":["dizziness","nausea","lipothymia","sustained ventricular tachycardia"]}}